ASTM: Summary for Aastrom Biosciences, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 12:01am EST - Canadian Markets open in 9 hours and 29 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Aastrom Biosciences, Inc. (ASTM)

On Feb 9: 0.1819 USD

0.0291 (13.79%)

MORE ON ASTM

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Aastrom Biosciences, Inc. (NCM:ASTM) Delayed quote data

After Hours: 0.18

0.0019 (1.04%) as of 7:59pm EST on 02/09/10

Last Trade:	0.1819 USD
Trade Time:	Feb 9
Change:	0.0291 (13.79%)
Prev Close:	0.211
Open:	0.185
Bid:	0.16 x 4000
Ask:	N/A
1y Target Est:	1.75

Day's Range:	0.165 - 0.19
52wk Range:	0.17 - 0.63
Volume:	15,084,948
Avg Vol (3m):	2,913,400
Market Cap:	31.65M
P/E (ttm):	N/A
EPS (ttm):	-0.155
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add ASTM to Portfolio

Download Data

HEADLINES

•	AASTROM BIOSCIENCES INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financia
	EDGAR Online (Tue 9:09am)

•	InPlay: Aastrom Biosciences announces one-for-eight reverse stock split
	Briefing.com (Tue 8:31am)

•	AASTROM BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi
	EDGAR Online (Wed, Jan 27)

•	Q+A-Skin cells transformed directly to nerve in study
	at Reuters (Wed, Jan 27)

•	Skymark Research Initiates Independent Research Coverage On Aastrom Biosciences, Inc.
	GlobeNewswire (Tue, Jan 19)

•	AASTROM BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement
	EDGAR Online (Fri, Jan 15)

•	Aastrom, Broadwind Energy: Late Day Volume Plays
	at TheStreet.com (Fri, Jan 15)

•	UPDATE - Aastrom Biosciences prices unit offering; shares fall
	at Reuters (Fri, Jan 15)

•	AASTROM BIOSCIENCES INC Files SEC form 8-K, Regulation FD Disclosure
	EDGAR Online (Fri, Jan 8)

•	AASTROM BIOSCIENCES INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year
	EDGAR Online (Thu, Dec 17)

More Headlines for ASTM...

ANALYST

EPS Est (next year) (Jun-08) :	N/A
EPS Est (in 2 years) (Jun-09) :	N/A
Avg Rec (current)*:	1.7
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Aastrom Biosciences, Inc. operates as a regenerative medicine company, focusing on the clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on its proprietary Tissue Repair Cell (TRC) tec...

Full Company Profile

Add to Portfolio

Email to a Friend

•